# A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy

> **NCT07407062** · — · NOT_YET_RECRUITING · sponsor: **AbbVie** · enrollment: 200 (estimated)

## Conditions studied

- Cancer - Ovarian

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07407062
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-28
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07407062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07407062, "A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07407062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*